BamSEC and AlphaSense Join Forces
Learn More

Editas Medicine Inc.

NASDAQ: EDIT    
Share price (12/20/24): $1.31    
Market cap (12/20/24): $108 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 4 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Information of the Type That the Registrant Customarily and Actually Treats as Private or Confidential. Double Asterisks Denote Omissions. First Amendment to the Second Amended and Restated Collaboration and License Agreement
12/34/56
EX-10.36
from 10-K 3 pages Omnibus Amendment
12/34/56
EX-10.27
from 10-K 2 pages Editas Medicine Director Compensation
12/34/56
EX-10.20
from 10-K 7 pages Editas Medicine, Inc. Inducement Restricted Stock Unit Agreement
12/34/56
EX-10.19
from 10-K 9 pages Editas Medicine, Inc. Inducement Stock Option Agreement
12/34/56
EX-10.10
from 10-K 6 pages Editas Medicine, Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.09
from 10-K 4 pages Restricted Stock Agreement 2015 Stock Incentive Plan
12/34/56
EX-10.08
from 10-K 5 pages Editas Medicine, Inc. Nonstatutory Stock Option Agreement
12/34/56
EX-10.07
from 10-K 5 pages Editas Medicine, Inc. Incentive Stock Option Agreement
12/34/56
EX-10.1
from 8-K 12 pages Amended and Restated Severance Benefits Plan
12/34/56
EX-10
from 10-Q 14 pages Material contract
12/34/56
EX-10.3
from 10-Q 8 pages ​ July 2, 2023 ​ ​ Linda Burkly, PH.D. ​ ​ Re: Offer of Employment ​ ​ Dear Linda, ​ on Behalf of Editas Medicine, Inc. (The “Company”), I Am Pleased to Offer You Employment With the Company. the Purpose of This Letter (The “Offer Letter”) Is to Set Forth the Terms of Your Employment With the Company, Should You Accept Our Offer
12/34/56
EX-10.2
from 10-Q 12 pages ​ via Hand Delivery May 11, 2023 (As Revised at Your Request on May 15, 2023) Michelle Robertson ​ Dear Michelle,
12/34/56
EX-10.1
from 10-Q 8 pages ​ May 12, 2023 ​ Erick Lucera ​ Re: Offer of Employment ​ Dear Erick, ​ on Behalf of Editas Medicine, Inc. (The “Company”), I Am Pleased to Offer You Employment With the Company. the Purpose of This Letter (The “Offer Letter”) Is to Set Forth the Terms of Your Employment With the Company, Should You Accept Our Offer
12/34/56
EX-10.32
from 10-K 3 pages First Amendment to Lease Agreement
12/34/56
EX-10.4
from 10-Q 1 page Amendment to Rsu Agreement
12/34/56
EX-10.3
from 10-Q 8 pages ​ June 09, 2022 ​ ​ ​ Baisong Mei, M.D., PH.D. ​ ​ ​ Re: Offer of Employment ​ ​ Dear Baisong, on Behalf of Editas Medicine, Inc. (The “Company”), I Am Pleased to Offer You Employment With the Company. the Purpose of This Letter (The “Offer Letter”) Is to Set Forth the Terms of Your Employment With the Company, Should You Accept Our Offer
12/34/56
EX-10.2
from 10-Q 3 pages ​ April 13, 2022 by Electronic Mail ​ James C. Mullen ​ Dear Jim
12/34/56
EX-10.1
from 10-Q 7 pages April 13, 2022 ​ by Electronic Mail ​ Gilmore O’neill, M.D. ​ Dear Gilmore: ​ on Behalf of Editas Medicine, Inc., a Delaware Corporation (The “Company”), I Am Pleased to Offer You Employment With the Company. the Purpose of This Letter Is to Summarize the Terms of Your Employment With the Company, Should You Accept Our Offer
12/34/56
EX-10.28
from 10-K 14 pages Severance Benefits Plan
12/34/56